Trajan Group (ASX:TRJ) Eyes Double-Digit nEBITDA Growth in FY27

Aditi Sarkar

08 October 2026 04:31 PM AEDT

Trajan Group (ASX:TRJ) Eyes Double-Digit nEBITDA Growth in FY27

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Trajan reported FY26 Revenue of $161.4 million and group nEBITDA of $13.2 million.
Second-half FY26 nEBITDA rose 61.8% on the first half to $8.1 million.
Q1 FY27 net revenue increased 3.8%, with nEBITDA of about $3.5 million.
FY27 guidance targets mid-single-digit organic revenue growth and double-digit nEBITDA growth.

Trajan Group Holdings Limited (ASX:TRJ) has released an investor presentation titled "Understanding Trajan", delivered by CEO and Managing Director Stephen Tomisich. The presentation covers the company's FY26 results, a first-quarter FY27 trading update and guidance for the year ahead.

FY26 Results and Second-Half Improvement

Trajan reported FY26 group revenue of $161.4 million, down 3.1%, and group nEBITDA of $13.2 million, down 14.7%. Operating NPATA rose to $2.2 million from $0.8 million.

Performance improved in the second half, with nEBITDA of $8.1 million, up 61.8% on the first half, and gross Margin of 40.6%. Cost initiatives, including headcount and Facility changes, pricing actions and Supply chain savings, supported the improvement.

Q1 FY27 Trading Update

Based on unaudited management accounts, Q1 FY27 net revenue increased 3.8% on Q1 FY26, with nEBITDA of about $3.5 million. Components and Consumables revenue grew 5.2%, while Capital Equipment declined 1.2%.

Net Debt was reduced by $1.6 million during the quarter. The company said Components and Consumables growth has returned to normal rates following earlier customer destocking.

FY27 Guidance and Business Profile

For FY27, Trajan expects mid-single-digit organic revenue growth and double-digit nEBITDA growth on the prior year. More specific targets are expected at the AGM on 28 October 2026.

Trajan develops and manufactures analytical and life science products, with about 600 staff across ten sites globally. More than 95% of revenue is generated outside Australia, and about 70% comes from recurring Components and Consumables sales.

Key Takeaways

Trajan's Earnings improved significantly in the second half of FY26.
Q1 FY27 revenue grew 3.8%, led by Components and Consumables.
The company is targeting double-digit nEBITDA growth in FY27.
More detailed guidance is expected at the AGM on 28 October 2026.

FAQs

Q: What did Trajan report for FY26?

A: FY26 revenue was $161.4 million and group nEBITDA was $13.2 million.

Q: How did the second half perform?

A: Second-half nEBITDA rose 61.8% on the first half to $8.1 million.

Q: What was Q1 FY27 revenue growth?

A: Net revenue increased 3.8% on Q1 FY26.

Q: What is Trajan's FY27 guidance?

A: Mid-single-digit organic revenue growth and double-digit nEBITDA growth.

Q: When is Trajan's AGM?

A: The AGM is on 28 October 2026.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.